Rallybio Corporation RLYB
15.90 USD +0.04 (+0.25%)
At closeNov 4, 2026, 5:23 PM EST
16.50 +0.60 +3.77%
After hours · Nov 4, 5:23 PM ET
15.45 Day range 16.17
3.67 52-week range 17.57
- YTD
- +189.62%
- 1 year
- +215.48%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 8.25 -48.1% downside
Now 15.90
- Target (low)
- 5.00
- Target (mean)
- 8.25
- Target (high)
- 13.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy2
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 6
- 3 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.29667 | -0.32 – -0.28 | -0.50 | +40.7% | 75.00K | 0.0% | 3 |
| Next quarter | -0.305 | -0.31 – -0.30 | -0.47 | +35.1% | 0 | 0.0% | 2 |
| Current year | -1.45 | -1.64 – -1.36 | -1.84 | +21.5% | 674.50K | 0.0% | 4 |
| Next year | -1.42 | -2.08 – -1.05 | -1.45 | +2.1% | 225.00K | -66.6% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 26, 2024 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 12, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 15, 2024 | JP Morgan | Downgrade | Overweight | Neutral |
| May 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 19, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 18, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 11, 2024 | Wedbush | Maintained | Outperform | Outperform |
| Mar 13, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Mar 13, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 7, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Feb 7, 2024 | Wedbush | Maintained | Outperform | Outperform |
| Feb 7, 2024 | Jefferies | Downgrade | Buy | Hold |
| Feb 7, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 21, 2023 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Nov 29, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 10, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Nov 10, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 5, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Sep 5, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 10, 2023 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 25, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Jun 30, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 26, 2023 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jun 26, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
